ATM-Ranking-2021

Access-To-Medicine: Ranking Progress and Focus on Early-Phase R&DBoehringer Ingelheim climbs two more places to rank 12 in 2021  Access-To-Medicine Index ​New early-stage research projects for disease areas relevant to low-to-middle income countries not reflected in index criteriaWide range of projects addressing health challenges in low- and middle-income countries recognized

Source: Boehringer Ingelheim Corporate News - January 26, 2021 Category: Research Source Type: news